title: Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research Use.
abstract: Screening tools to identify HIV-associated neurocognitive disorder (HAND) are primarily devised to detect cognitive impairment on a single occasion. With the chronicity of HIV infection and the risk of HAND developing or progressing despite viral control, it may be pertinent to repeat HAND screening at more than one time point. Despite this, there are limited data on longitudinal use of such screening tools, particularly with regard to the role of practice effects. Additionally, no guidelines currently exist on the timeframe between testing intervals, or recommendation of the magnitude of baseline impairment that warrants follow-up testing. The aim of the current paper was to review existing evidence for longitudinal validity of HAND screening tools. Only those HAND screening tools previously found to have high cross-sectional criterion validity were included. Preliminary recommendations for clinical use and future research are proposed including in international settings.
authors.affiliation: Neuroscience Research Australia, 139 Barker Street, Randwick, NSW, 2031, Australia.|Ongoing and Extended Care Services, Hunter New England Local Health District, Armidale Community Health, Armidale, NSW, 2350, Australia.
authors.forename: Jody
authors.initials: J
authors.lastname: Kamminga
authors.affiliation: The Burnet Institute, Melbourne, VIC, 3004, Australia.|The Alfred Hospital, Melbourne, VIC, 3004, Australia.
authors.forename: Luxshimi
authors.initials: L
authors.lastname: Lal
authors.affiliation: The Burnet Institute, Melbourne, VIC, 3004, Australia.|The Alfred Hospital, Melbourne, VIC, 3004, Australia.|Monash University, Clayton, VIC, 3800, Australia.
authors.forename: Edwina J
authors.initials: EJ
authors.lastname: Wright
authors.affiliation: Faculty of Medicine, The University of New South Wales, Sydney, NSW, 2052, Australia.|Holdsworth House Medical Practice, Sydney, NSW, 2000, Australia.
authors.forename: Mark
authors.initials: M
authors.lastname: Bloch
authors.affiliation: Faculty of Medicine, The University of New South Wales, Sydney, NSW, 2052, Australia.|St. Vincent's Hospital Applied Medical Research Center, The Peter Duncan Neuroscience Unit, Darlinghurst, NSW, 2010, Australia.|Neurology and HIV Departments, St. Vincent's Hospital, Darlinghurst, NSW, 2010, Australia.
authors.forename: Bruce J
authors.initials: BJ
authors.lastname: Brew
authors.affiliation: Neuroscience Research Australia, 139 Barker Street, Randwick, NSW, 2031, Australia. lcysique@unsw.edu.au.|Faculty of Medicine, The University of New South Wales, Sydney, NSW, 2052, Australia. lcysique@unsw.edu.au.|St. Vincent's Hospital Applied Medical Research Center, The Peter Duncan Neuroscience Unit, Darlinghurst, NSW, 2010, Australia. lcysique@unsw.edu.au.|Neurology and HIV Departments, St. Vincent's Hospital, Darlinghurst, NSW, 2010, Australia. lcysique@unsw.edu.au.
authors.forename: Lucette A
authors.initials: LA
authors.lastname: Cysique
mesh_terms: D015526:AIDS Dementia Complex / Q000175:diagnosis*; D003072:Cognition Disorders / Q000175:diagnosis*; D015658:HIV Infections / Q000150:complications* / Q000523:psychology; D006801:Humans; D008403:Mass Screening / Q000379:methods; D009483:Neuropsychological Tests; D017410:Practice Guidelines as Topic; D015203:Reproducibility of Results; D012106:Research
keywords: Aids; Cognitive screen; Computerized screen; HIV; HIV dementia scale; Hand; International settings; Longitudinal studies; Neuropsychology; Reliability